iBio Inc (IBIO)
2.19
-0.07
(-3.10%)
USD |
NYAM |
Oct 04, 16:00
2.20
+0.01
(+0.46%)
Pre-Market: 20:00
iBio Shareholders Equity (Annual): 21.32M for June 30, 2024
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 21.32M |
June 30, 2023 | 15.38M |
June 30, 2022 | 63.48M |
June 30, 2021 | 108.58M |
June 30, 2020 | 56.62M |
June 30, 2019 | 2.463M |
June 30, 2018 | 16.17M |
June 30, 2017 | 8.914M |
June 30, 2016 | 9.937M |
Date | Value |
---|---|
June 30, 2015 | 11.23M |
June 30, 2014 | 6.099M |
June 30, 2013 | 5.068M |
June 30, 2012 | 6.169M |
June 30, 2011 | 0.1966M |
June 30, 2010 | 1.076M |
June 30, 2009 | 4.388M |
June 30, 2008 | -6.203M |
June 30, 2007 | -4.333M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
15.38M
Minimum
2023
108.58M
Maximum
2021
53.08M
Average
56.62M
Median
2020
Shareholders Equity (Annual) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Nanoviricides Inc | 11.46M |